Pharmsynthez (MOEX:LIFE)
Russia · Delayed Price · Currency is RUB 4.505
+0.415 (10.15%)
At close: Jul 8, 2022
Pharmsynthez Company Description
Public Joint-Stock Company "Pharmsynthez", a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia, Europe, the United States, and CIS countries.
The company offers officinal medicines, including Neovir, Segidrin, Glaumax, Vazostenon, Neostim, Fludarabel, Fenazide, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis.
Public Joint-Stock Company "Pharmsynthez" was founded in 1996 and is based in St. Petersburg, Russia.
Pharmsynthez
| Country | Russia |
| Founded | 1996 |
| Industry | Pharmaceutical Preparations |
| CEO | Petr Kurglyakov |
Contact Details
Address: 25 Krasnovo Kursanta Str St. Petersburg, 197 110 Russia | |
| Phone | 7 812 329 8080 |
| Website | pharmsynthez.com |
Stock Details
| Ticker Symbol | LIFE |
| Exchange | Moscow Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | RUB |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Petr Kurglyakov | Chief Executive Officer |